Disease,Disease_id,Gene,Gene_id,Score_gda,Association_Type, Type,Original_DB,Sentence,PMID,PMID_Year
Oral Mucositis,C1568868,TGFB1,7040,0.01,Biomarker,,BEFREE,"Immunohistochemistry was used for angiogenesis (CD31) and <span class=""gene"" id=""30672024-8-58-91"">transforming growth factor beta 1</span> (<span class=""gene"" id=""30672024-8-93-99"">TGF-β1</span>) analysis.On Day 5, all groups exhibited <span class=""disease"" id=""30672024-8-141-143"">OM</span>.",30672024,2019
Oral Mucositis,C1568868,SMAD7,4092,0.01,Biomarker,,BEFREE,"Our results suggest that short-course Tat-<span class=""gene"" id=""30185419-7-42-47"">Smad7</span> application to <span class=""disease"" id=""30185419-7-63-77"">oral mucositis</span> promotes its healing but does <span class=""negexp"">not compromise the cytotoxic effect</span> of RT on oral cancer and has context-specific effects on oral mucosa versus oral cancer.",30185419,2019
Oral Mucositis,C1568868,FGF7,2252,0.06,Biomarker,,BEFREE,"Prevention of radiation-induced <span class=""disease"" id=""19584147-0-32-46"">oral mucositis</span> after adenoviral vector-mediated transfer of the <span class=""gene"" id=""19584147-0-96-122"">keratinocyte growth factor</span> cDNA to mouse submandibular glands.",19584147,2009
Oral Mucositis,C1568868,CCND1,595,0.01,GeneticVariation,,BEFREE,"In some subgroups, cyclin D1 gene <span class=""gene"" id=""28445979-7-34-39"">CCND1</span> <span class=""variant"" dbSNP=""rs9344"" genes_norm=""1029;1033;3551;4790;595"">rs9344</span> and inhibitor of κB kinase gene IKBKB <span class=""variant"" dbSNP=""rs12676482"" genes_norm=""1029;1033;3551;4790;595"">rs12676482</span> were related with the grade 3-4 acute radiation-induced myelosuppression, and <span class=""gene"" id=""28445979-7-174-179"">CCND1</span> <span class=""variant"" dbSNP=""rs9344"" genes_norm=""1029;1033;3551;4790;595"">rs9344</span> was also associated with grade 3-4 acute radiation-induced <span class=""disease"" id=""28445979-7-246-260"">oral mucositis</span>.",28445979,2017
Oral Mucositis,C1568868,H2AX,3014,0.01,Biomarker,,BEFREE,"The correlation between residual DSBs and the severity of acute reactions demonstrated that residual γ-<span class=""gene"" id=""22836053-5-103-107"">H2AX</span> foci in head-and-neck cancer patients increased with the severity of <span class=""disease"" id=""22836053-5-177-191"">oral mucositis</span> and skin reaction.",22836053,2012
Oral Mucositis,C1568868,XRCC6,2547,0.01,GeneticVariation,,BEFREE,"Our study suggests that the <span class=""gene"" id=""24350917-13-28-32"">Ku70</span> c.1781G&gt; T polymorphism may be a susceptibility factor for radiation-induced <span class=""disease"" id=""24350917-13-110-124"">oral mucositis</span> in Chinese nasopharyngeal carcinoma patients.",24350917,2014
Oral Mucositis,C1568868,FGF7,2252,0.06,Biomarker,,BEFREE,"We are confident that <span class=""gene"" id=""29181845-28-22-25"">KGF</span> is beneficial in the prevention of <span class=""disease"" id=""29181845-28-61-75"">oral mucositis</span> in adults who are receiving: a) radiotherapy to the head and neck with cisplatin or fluorouracil; or b) chemotherapy alone for mixed solid and haematological cancers.",29181845,2017
Oral Mucositis,C1568868,CYP2B6,1555,0.01,Biomarker,,BEFREE,"Among other clinical and genetic factors, polymorphisms of <span class=""gene"" id=""19005482-7-59-65"">CYP2B6</span> genes that interfere with cyclophosphamide metabolism were associated with <span class=""disease"" id=""19005482-7-141-143"">OM</span> (recipient <span class=""gene"" id=""19005482-7-155-161"">CYP2B6</span>(*)4; P=0.0067), HC (recipient <span class=""gene"" id=""19005482-7-192-198"">CYP2B6</span>(*)2; P=0.03) and VOD (donor <span class=""gene"" id=""19005482-7-227-233"">CYP2B6</span>(*)6; P=0.03).",19005482,2009
Oral Mucositis,C1568868,PERCC1,105371045,0.01,Biomarker,,BEFREE,"We describe <span class=""disease"" id=""29277788-2-12-14"">OM</span> in <span class=""gene"" id=""29277788-2-18-21"">ICR</span> mice induced using 5-fluorouracil (5-FU) and 20% acetic acid.",29277788,2018
Oral Mucositis,C1568868,RRM1,6240,0.01,GeneticVariation,,BEFREE,"The evaluation of <span class=""gene"" id=""29865035-8-18-22"">RRM1</span> gene expression in cfRNA allows for estimation of the risk of severe <span class=""disease"" id=""29865035-8-92-94"">OM</span> in patients subjected to RTH.",29865035,2018
Oral Mucositis,C1568868,TFF3,7033,0.01,Biomarker,,BEFREE,"Phase II, randomized, double-blind, placebo-controlled study of recombinant human <span class=""gene"" id=""19636011-0-82-107"">intestinal trefoil factor</span> oral spray for prevention of <span class=""disease"" id=""19636011-0-137-151"">oral mucositis</span> in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.",19636011,2009
Oral Mucositis,C1568868,XRCC1,7515,0.34,GeneticVariation,,BEFREE,"Our investigation shows, for the first time, that patients with the <span class=""gene"" id=""23375119-11-68-73"">XRCC1</span> <span class=""variant"" dbSNP=""rs25487"" genes_norm=""7515"">399Arg/Gln</span> genotype were more likely to experience severe acute dermatitis and <span class=""disease"" id=""23375119-11-153-167"">oral mucositis</span>.",23375119,2013
Oral Mucositis,C1568868,EPO,2056,0.02,GeneticVariation,,BEFREE,"Moreover, the mean ± SD duration of <span class=""disease"" id=""26310513-8-36-38"">OM</span> was also significantly shorter among the <span class=""gene"" id=""26310513-8-80-83"">EPO</span> mouthwash recipients (1.92 ± 3.42 days vs 5.42 ± 3.86 days, P &lt; 0.001).",26310513,2017
Oral Mucositis,C1568868,FGF7,2252,0.06,Biomarker,,BEFREE,"The recombinant human truncated <span class=""gene"" id=""30999249-1-32-58"">Keratinocyte growth factor</span> (<span class=""gene"" id=""30999249-1-60-70"">Palifermin</span>) is the only FDA approved medicine for the treatment of <span class=""disease"" id=""30999249-1-127-141"">oral mucositis</span>.",30999249,2019
Oral Mucositis,C1568868,GRHL3,57822,0.01,Biomarker,,BEFREE,"Although the primary endpoint was not met, the positive trends of <span class=""disease"" id=""31669562-8-66-68"">OM</span>-associated outcomes suggest that the novel mucoadhesive tablet delivery of clonidine might favorably affect the course and severity of CRT-induced <span class=""gene"" id=""31669562-8-216-219"">SOM</span> and support further evaluation.",31669562,2020
Oral Mucositis,C1568868,EGF,1950,0.02,Biomarker,,BEFREE,"Topical Recombinant Human <span class=""gene"" id=""28045958-0-26-49"">Epidermal Growth Factor</span> for <span class=""disease"" id=""28045958-0-54-68"">Oral Mucositis</span> Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.",28045958,2017
Oral Mucositis,C1568868,APEH,327,0.01,GeneticVariation,,BEFREE,"Polymorphism of regulatory region of <span class=""gene"" id=""30038710-0-37-41"">APEH</span> gene (c.-521G&gt;C, <span class=""variant"" dbSNP=""rs4855883"" genes_norm=""327"">rs4855883</span>) as a relevant predictive factor for radiotherapy induced <span class=""disease"" id=""30038710-0-127-141"">oral mucositis</span> and overall survival in head neck cancer patients.",30038710,2018
Oral Mucositis,C1568868,XRCC3,7517,0.01,Biomarker,,BEFREE,"The meta-analysis showed an expression of polymorphisms in XRCC1 (32.66%), <span class=""gene"" id=""28623401-7-75-80"">XRCC3</span> (31.00%), and RAD51 (39.16%) genes, as well as an expression of protein biomarkers (39.57%), in patients with an increased risk of developing <span class=""disease"" id=""28623401-7-223-237"">oral mucositis</span>.",28623401,2017
Oral Mucositis,C1568868,XRCC1,7515,0.34,Biomarker,,CTD_human,"In addition, genetic linkage disequilibrium existed in <span class=""gene"" id=""24594932-7-55-60"">XRCC1</span> polymorphisms for &gt;grade 2 <span class=""disease"" id=""24594932-7-88-102"">oral mucositis</span> and skin reaction indicating the complex inheritance pattern.",24594932,2014
Oral Mucositis,C1568868,CSF3,1440,0.31,Biomarker,,BEFREE,"The effects of recombinant human <span class=""gene"" id=""28791814-0-33-70"">granulocyte colony-stimulating factor</span> mouthwash on radiotherapy-induced <span class=""disease"" id=""28791814-0-105-119"">oral mucositis</span> in locally advanced nasopharyngeal carcinoma patients.",28791814,2017
Oral Mucositis,C1568868,MIR1206,100302170,0.01,GeneticVariation,,BEFREE,"Our results replicate the association between <span class=""variant"" dbSNP=""rs2114358"" genes_norm=""100302170;100302225;1233;4850"">rs2114358</span> in <span class=""gene"" id=""28628559-8-59-67"">miR-1206</span> and MTX-induced <span class=""disease"" id=""28628559-8-84-98"">oral mucositis</span> in childhood ALL.",28628559,2017
Oral Mucositis,C1568868,IL1B,3553,0.01,Biomarker,,BEFREE,"Early inflammation, as indicated by the expression of the inflammatory markers TNFα, NF-κB, and <span class=""gene"" id=""28258409-11-96-101"">IL-1β</span>, is an essential component of early radiogenic <span class=""disease"" id=""28258409-11-149-163"">oral mucositis</span>.",28258409,2017
Oral Mucositis,C1568868,ALB,213,0.03,Biomarker,,BEFREE,"Type of treatment protocol, baseline estimated glomerular filtration rate, and melphalan dose along with baseline <span class=""gene"" id=""25218607-8-114-127"">serum albumin</span> and female gender predicted 43.6 % of grades 2-4 <span class=""disease"" id=""25218607-8-177-179"">OM</span> cases.",25218607,2015
Oral Mucositis,C1568868,AGT,183,0.01,Biomarker,,BEFREE,"Protective effect of <span class=""gene"" id=""30125396-0-21-35"">angiotensin II</span> receptor blocker against oxidative stress and inflammation in an <span class=""disease"" id=""30125396-0-101-115"">oral mucositis</span> experimental model.",30125396,2018
Oral Mucositis,C1568868,IL1A,3552,0.01,AlteredExpression,,BEFREE,"To assess changes in the salivary expression of <span class=""gene"" id=""28403570-1-48-53"">IL-1α</span>, IL-1β, IL-2, IL-6, IL-10, IL-17, and TNF in acute leukemia (AL) patients before and during chemotherapy, and its association with HSV infection, oral candidiasis (OC), and <span class=""disease"" id=""28403570-1-227-241"">oral mucositis</span> (OM) onset.",28403570,2017
Oral Mucositis,C1568868,FGF2,2247,0.01,Biomarker,,BEFREE,"We investigated the effect of <span class=""gene"" id=""29034752-2-30-60"">basic fibroblast growth factor</span> on radiation-induced <span class=""disease"" id=""29034752-2-82-96"">oral mucositis</span> in male Syrian hamsters.",29034752,2017
Oral Mucositis,C1568868,MIR200C,406985,0.01,Biomarker,,BEFREE,"<span class=""gene"" id=""31346357-0-0-8"">miR-200c</span> Modulates the Pathogenesis of Radiation-Induced <span class=""disease"" id=""31346357-0-57-71"">Oral Mucositis</span>.",31346357,2019
Oral Mucositis,C1568868,ESR1,2099,0.01,Biomarker,,BEFREE,"Oral Care Evaluation to Prevent <span class=""disease"" id=""31594912-0-32-46"">Oral Mucositis</span> in <span class=""gene"" id=""31594912-0-50-67"">Estrogen Receptor</span>-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.",31594912,2019
Oral Mucositis,C1568868,MTHFR,4524,0.02,GeneticVariation,,BEFREE,"Patients who are scheduled to receive conditioning regimens containing TBI, have a pretransplant body mass index &gt;or= 25, or carry the <span class=""gene"" id=""15051775-9-135-170"">methylenetetrahydrofolate reductase</span> 677 TT genotype should be considered at greater risk of developing <span class=""disease"" id=""15051775-9-238-252"">oral mucositis</span> following HCT.",15051775,2004
Oral Mucositis,C1568868,ABCB1,5243,0.02,GeneticVariation,,BEFREE,"The presence of <span class=""gene"" id=""29885788-9-16-21"">ABCB1</span> 3435-T, ABCC2 3972-C, ABCC2 1249-G, and <span class=""gene"" id=""29885788-9-62-67"">ABCB1</span> 2677-G alleles was significantly associated with nausea and <span class=""disease"" id=""29885788-9-128-142"">oral mucositis</span>.",29885788,2018
Oral Mucositis,C1568868,TNF,7124,0.05,Biomarker,,BEFREE,"A secondary purpose was to assess the effectiveness of molecular biology methods for measuring <span class=""gene"" id=""18164921-4-95-104"">TNF-alpha</span> concentrations in plasma, saliva, and buccal epithelial cells in patients with <span class=""disease"" id=""18164921-4-184-198"">oral mucositis</span> undergoing HSCT.",18164921,2007
Oral Mucositis,C1568868,DPYD,1806,0.02,GeneticVariation,,BEFREE,"It was lower <span class=""gene"" id=""28278081-7-13-16"">DPD</span> activity that responsible for the relatively higher incidence of bone marrow hypocellular, diarrhea, and <span class=""disease"" id=""28278081-7-122-136"">oral mucositis</span> in the C&lt;sub&gt;SN-38 1.5 h&lt;/sub&gt; &gt; 50.24 ng/ml and C&lt;sub&gt;SN-38 49 h&lt;/sub&gt; &gt; 15.25 ng/ml subsets.",28278081,2017
Oral Mucositis,C1568868,NARS1,4677,0.01,Biomarker,,BEFREE,"These studies used several classifications for <span class=""disease"" id=""31092370-6-47-49"">OM</span> (RTOG/EORTC, WHO, NCI-CTC) and pain (<span class=""gene"" id=""31092370-6-87-90"">NRS</span>, VAS and modified VAS).",31092370,2019
Oral Mucositis,C1568868,EGF,1950,0.02,Biomarker,,BEFREE,"Effects of Glycine on Collagen, PDGF, and <span class=""gene"" id=""30322002-0-42-45"">EGF</span> Expression in Model of <span class=""disease"" id=""30322002-0-69-83"">Oral Mucositis</span>.",30322002,2018
Oral Mucositis,C1568868,PPARG,5468,0.01,Biomarker,,BEFREE,"<span class=""gene"" id=""29155481-0-0-48"">Peroxisome proliferator activated receptor-gamma</span> stimulation for prevention of 5-fluorouracil-induced <span class=""disease"" id=""29155481-0-102-116"">oral mucositis</span> in mice.",29155481,2018
Oral Mucositis,C1568868,PECAM1,5175,0.01,Biomarker,,BEFREE,"Immunohistochemistry was used for angiogenesis (<span class=""gene"" id=""30672024-8-48-52"">CD31</span>) and transforming growth factor beta 1 (TGF-β1) analysis.On Day 5, all groups exhibited <span class=""disease"" id=""30672024-8-141-143"">OM</span>.",30672024,2019
Oral Mucositis,C1568868,FGF7,2252,0.06,Biomarker,,BEFREE,"Specifically, <span class=""gene"" id=""24188496-8-14-17"">KGF</span> is currently being evaluated in clinical trials sponsored by Amgen (Thousand Oaks, CA) to test its ability to ameliorate severe <span class=""disease"" id=""24188496-8-146-160"">oral mucositis</span> (<span class=""disease"" id=""24188496-8-162-164"">OM</span>) that results from cancer chemoradiotherapy.",24188496,2014
Oral Mucositis,C1568868,FGF7,2252,0.06,Biomarker,,BEFREE,"In 2005, palifermin [recombinant human <span class=""gene"" id=""18708365-3-39-65"">keratinocyte growth factor</span> (<span class=""gene"" id=""18708365-3-67-70"">KGF</span>)] was approved to decrease the incidence and duration of severe <span class=""disease"" id=""18708365-3-135-149"">oral mucositis</span> in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support.",18708365,2008
Oral Mucositis,C1568868,FGF7,2252,0.06,Biomarker,,BEFREE,"<span class=""gene"" id=""15327889-7-0-3"">KGF</span> is currently being evaluated in clinical trials to test its ability to ameliorate severe <span class=""disease"" id=""15327889-7-93-107"">oral mucositis</span> (<span class=""disease"" id=""15327889-7-109-111"">OM</span>) that results from cancer chemoradiotherapy.",15327889,2004
Oral Mucositis,C1568868,CNOT4,4850,0.01,GeneticVariation,,BEFREE,"<span class=""disease"" id=""28628559-7-0-14"">Oral mucositis</span> was defined as grade more than or equal to 3 according to the National Cancer Institute criteria. <span class=""variant"" dbSNP=""rs2114358"" genes_norm=""100302170;100302225;1233;4850"">rs2114358</span> in miR-1206 was associated with <span class=""disease"" id=""28628559-7-155-169"">oral mucositis</span> [odds ratio (OR): 3.6; 95% confidence interval (CI): 1.1-11.5], whereas we did <span class=""negexp"">not confirm the association</span> of <span class=""gene"" id=""28628559-7-280-285"">CNOT4</span> <span class=""variant"" dbSNP=""rs3812265"" genes_norm=""100302170;100302225;1233;4850"">rs3812265</span> (OR: 0.69; 95% CI: 0.27-1.80) and miR-2053 <span class=""variant"" dbSNP=""rs10505168"" genes_norm=""100302170;100302225;1233;4850"">rs10505168</span> (OR: 2.50; 95% CI: 0.76-8.24).",28628559,2017
Oral Mucositis,C1568868,ALB,213,0.03,Biomarker,,BEFREE,"The patients' age, sex, body mass index, primary site, diabetes, <span class=""gene"" id=""31177394-3-65-78"">serum albumin</span>, creatinine, hemoglobin, leukocyte and lymphocyte, concurrent cisplatin or cetuximab, method of radiation, total radiation dose, feeding route, use of spacers, pilocarpine hydrochloride, and corticosteroid ointment were examined, and the associations of each variable with <span class=""disease"" id=""31177394-3-352-366"">oral mucositis</span> and candidiasis were analyzed by multivariate Cox regression analysis.",31177394,2020
Oral Mucositis,C1568868,MIR2053,100302225,0.01,GeneticVariation,,BEFREE,"<span class=""disease"" id=""28628559-7-0-14"">Oral mucositis</span> was defined as grade more than or equal to 3 according to the National Cancer Institute criteria. <span class=""variant"" dbSNP=""rs2114358"" genes_norm=""100302170;100302225;1233;4850"">rs2114358</span> in miR-1206 was associated with <span class=""disease"" id=""28628559-7-155-169"">oral mucositis</span> [odds ratio (OR): 3.6; 95% confidence interval (CI): 1.1-11.5], whereas we did <span class=""negexp"">not confirm the association</span> of CNOT4 <span class=""variant"" dbSNP=""rs3812265"" genes_norm=""100302170;100302225;1233;4850"">rs3812265</span> (OR: 0.69; 95% CI: 0.27-1.80) and <span class=""gene"" id=""28628559-7-330-338"">miR-2053</span> <span class=""variant"" dbSNP=""rs10505168"" genes_norm=""100302170;100302225;1233;4850"">rs10505168</span> (OR: 2.50; 95% CI: 0.76-8.24).",28628559,2017
Oral Mucositis,C1568868,XRCC1,7515,0.34,GeneticVariation,,BEFREE,"In addition, genetic linkage disequilibrium existed in <span class=""gene"" id=""24594932-7-55-60"">XRCC1</span> polymorphisms for &gt;grade 2 <span class=""disease"" id=""24594932-7-88-102"">oral mucositis</span> and skin reaction indicating the complex inheritance pattern.",24594932,2014
Oral Mucositis,C1568868,IFNA2,3440,0.3,Biomarker,,CTD_human,All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma.,9234591,1997
Oral Mucositis,C1568868,TYMS,7298,0.01,GeneticVariation,,BEFREE,"We determined the role of three previously described variants within the <span class=""gene"" id=""30222710-4-73-77"">TYMS</span> gene and MTX-induced <span class=""disease"" id=""30222710-4-99-113"">oral mucositis</span> in a prospective cohort of Dutch children with ALL and performed a meta-analysis of the previous results.",30222710,2018
Oral Mucositis,C1568868,MTX1,4580,0.01,Biomarker,,BEFREE,"Even though future studies are necessary, higher cumulative Leucovorin doses and early initiation of Leucovorin after start of <span class=""gene"" id=""31323533-8-127-130"">MTX</span> seem to reduce <span class=""disease"" id=""31323533-8-146-160"">oral mucositis</span>.",31323533,2019
Oral Mucositis,C1568868,XRCC1,7515,0.34,Biomarker,,BEFREE,"The meta-analysis showed an expression of polymorphisms in <span class=""gene"" id=""28623401-7-59-64"">XRCC1</span> (32.66%), XRCC3 (31.00%), and RAD51 (39.16%) genes, as well as an expression of protein biomarkers (39.57%), in patients with an increased risk of developing <span class=""disease"" id=""28623401-7-223-237"">oral mucositis</span>.",28623401,2017
Oral Mucositis,C1568868,XRCC1,7515,0.34,GeneticVariation,,BEFREE,"T stage and smoking status were significantly associated with acute radiation <span class=""disease"" id=""29095251-4-78-92"">oral mucositis</span> with Grade ≥2 (OR = 2.508, P = .001, 95% CI: 1.427-4.408, OR = 6.355, P &lt; .001, 95% CI: 2.533-15.841).The <span class=""gene"" id=""29095251-4-199-204"">XRCC1</span> codon 399 genotype in NPC could be an important predicting factor in the risk of acute radiation dermatitis during IMRT.",29095251,2017
Oral Mucositis,C1568868,ALB,213,0.03,AlteredExpression,,BEFREE,"Low baseline blood <span class=""gene"" id=""28948645-11-19-26"">albumin</span> levels in the <span class=""disease"" id=""28948645-11-41-43"">OM</span>-affected individuals were identified, revealing the effect of systemic deterioration as a predisposing factor for <span class=""disease"" id=""28948645-11-158-160"">OM</span> development.No adverse effects were observed.",28948645,2018
Oral Mucositis,C1568868,TNF,7124,0.05,GeneticVariation,,BEFREE,"Single nucleotide polymorphism (SNP) of the <span class=""gene"" id=""31076897-5-44-49"">TNF-α</span> promoter region can potentially affect the function or expression of this cytokine, and thus modulate the risk of occurrence and intensity of <span class=""disease"" id=""31076897-5-192-194"">OM</span> and shortening of overall survival (OS).",31076897,2020
Oral Mucositis,C1568868,TBC1D9,23158,0.01,GeneticVariation,,BEFREE,"<span class=""disease"" id=""23244145-5-0-14"">Oral mucositis</span> were detected in 78.7% (n=37) of the patients and significantly related to the <span class=""gene"" id=""23244145-5-94-99"">MDR-1</span> CT genotype (p=0.042), as confirmed by logistic regression analysis.",23244145,2012
Oral Mucositis,C1568868,TNF,7124,0.05,AlteredExpression,,BEFREE,"Compared with blank or vehicle-treated hamsters, the irradiated mucosa treated with phenylbutyrate had significantly lower oxidative stress and <span class=""gene"" id=""19351790-8-144-171"">tumor necrosis factor-alpha</span> expression and less severe <span class=""disease"" id=""19351790-8-199-213"">oral mucositis</span> of a shorter duration.",19351790,2009
Oral Mucositis,C1568868,SPNS1,83985,0.01,Biomarker,,BEFREE,"These studies used several classifications for <span class=""disease"" id=""31092370-6-47-49"">OM</span> (RTOG/EORTC, WHO, NCI-CTC) and pain (<span class=""gene"" id=""31092370-6-87-90"">NRS</span>, VAS and modified VAS).",31092370,2019
Oral Mucositis,C1568868,IKBKB,3551,0.01,GeneticVariation,,BEFREE,"In some subgroups, cyclin D1 gene CCND1 <span class=""variant"" dbSNP=""rs9344"" genes_norm=""1029;1033;3551;4790;595"">rs9344</span> and inhibitor of κB kinase gene <span class=""gene"" id=""28445979-7-79-84"">IKBKB</span> <span class=""variant"" dbSNP=""rs12676482"" genes_norm=""1029;1033;3551;4790;595"">rs12676482</span> were related with the grade 3-4 acute radiation-induced myelosuppression, and CCND1 <span class=""variant"" dbSNP=""rs9344"" genes_norm=""1029;1033;3551;4790;595"">rs9344</span> was also associated with grade 3-4 acute radiation-induced <span class=""disease"" id=""28445979-7-246-260"">oral mucositis</span>.",28445979,2017
Oral Mucositis,C1568868,GHRL,51738,0.01,GeneticVariation,,BEFREE,"The study results have demonstrated an association between the AA genotype of the <span class=""gene"" id=""29566446-8-82-86"">GHRL</span> gene and the risk of more severe <span class=""disease"" id=""29566446-8-120-134"">oral mucositis</span> attributed to RT in patients with head and neck cancer.",29566446,2018
Oral Mucositis,C1568868,FBXO3,26273,0.01,GeneticVariation,,BEFREE,"The incidences of diarrhea and severe <span class=""disease"" id=""30337697-6-38-52"">oral mucositis</span> within the first 30 days post-transplantation were lower in the <span class=""gene"" id=""30337697-6-117-120"">FBA</span> group [(28.57% versus 65.45%; P &lt; 0.001) (51.79% versus 70.91%; P = 0.039)].",30337697,2019
Oral Mucositis,C1568868,CSF3,1440,0.31,Biomarker,,CTD_human,Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.,12085204,2002
Oral Mucositis,C1568868,TNF,7124,0.05,AlteredExpression,,BEFREE,"Patients with HSV infection, OC, and <span class=""disease"" id=""28403570-9-37-39"">OM</span> showed higher salivary <span class=""gene"" id=""28403570-9-63-66"">TNF</span> levels during follow-up (HR: 3.52, 95% CI: 1.35-9.14, p = 0.010).",28403570,2017
Oral Mucositis,C1568868,GSK3B,2932,0.01,GeneticVariation,,BEFREE,"Moreover, <span class=""gene"" id=""27769064-7-10-15"">GSK3β</span> <span class=""variant"" dbSNP=""rs375557"" genes_norm=""1499;2932"">rs375557</span> and adenomatous polyposis coli gene (APC) <span class=""variant"" dbSNP=""rs454886"" genes_norm=""1499;2932"">rs454886</span> polymorphisms were correlated with acute grade 3-4 radiation-induced dermatitis and <span class=""disease"" id=""27769064-7-160-174"">oral mucositis</span>, respectively.",27769064,2016
Oral Mucositis,C1568868,LGR5,8549,0.01,Biomarker,,BEFREE,"<span class=""disease"" id=""31497199-5-0-14"">Oral mucositis</span> (OM) was induced by IR of the oral region of &lt;i&gt;<span class=""gene"" id=""31497199-5-63-67"">Lgr5</span>-lacZ&lt;/i&gt; transgenic mice.",31497199,2019
Oral Mucositis,C1568868,MTHFR,4524,0.02,GeneticVariation,,BEFREE,"Results suggested that <span class=""gene"" id=""22528943-5-23-28"">MTHFR</span> <span class=""variant"" dbSNP=""rs1217691063"" genes_norm=""4524"">C677T</span> polymorphism was associated with significantly increased risk of MTX-induced toxicity, specifically liver toxicity (TT/CT vs. CC: odds ratio (OR) = 1.70, 95 % confidence interval (CI) = 1.05-2.75), myelosuppression (TT vs. CT/CC: OR = 2.82, 95 %CI = 1.25-6.34), <span class=""disease"" id=""22528943-5-297-311"">oral mucositis</span> (TT/CT vs. CC: OR = 3.68, 95 %CI = 1.73-7.85), gastrointestinal toxicity (TT/CT vs. CC: OR = 2.36, 95 %CI = 1.36-4.11), and skin toxicity (T vs. C: OR = 2.26, 95 %CI = 1.07-4.74).",22528943,2012
Oral Mucositis,C1568868,TNF,7124,0.05,Biomarker,,BEFREE,"Proinflammatory cytokines (including <span class=""gene"" id=""28401452-4-37-42"">TNF-α</span>) play a key role in the development of <span class=""disease"" id=""28401452-4-82-84"">OM</span>.Genetic alterations, i.e. single nucleotide polymorphisms (SNPs) within genes encoding for receptors for <span class=""gene"" id=""28401452-4-190-193"">TNF</span> (ie.TNFRSF1A) may change their function.",28401452,2018
Oral Mucositis,C1568868,DMRTA1,63951,0.01,Biomarker,,BEFREE,"Eleven SNPs located in or near matrix metalloproteinase 13, JPH3, DHRS7C, CEP192, CPEB1/LINC00692, FBN2, ALDH1A1, and <span class=""gene"" id=""25218607-9-118-124"">DMRTA1</span>/FLJ35282 were associated with grades 2-4 <span class=""disease"" id=""25218607-9-166-168"">OM</span>.",25218607,2015
Oral Mucositis,C1568868,IL17A,3605,0.01,Biomarker,,BEFREE,"To assess changes in the salivary expression of IL-1α, IL-1β, IL-2, IL-6, IL-10, <span class=""gene"" id=""28403570-1-81-86"">IL-17</span>, and TNF in acute leukemia (AL) patients before and during chemotherapy, and its association with HSV infection, oral candidiasis (OC), and <span class=""disease"" id=""28403570-1-227-241"">oral mucositis</span> (OM) onset.",28403570,2017
Oral Mucositis,C1568868,DPYD,1806,0.02,AlteredExpression,,BEFREE,"The incidence of bone marrow suppression, diarrhea, and <span class=""disease"" id=""25388847-8-56-70"">oral mucositis</span> was high in patients with low <span class=""gene"" id=""25388847-8-101-104"">DPD</span> mRNA expression.",25388847,2015
Oral Mucositis,C1568868,TNFRSF1A,7132,0.01,GeneticVariation,,BEFREE,"Proinflammatory cytokines (including TNF-α) play a key role in the development of <span class=""disease"" id=""28401452-4-82-84"">OM</span>.Genetic alterations, i.e. single nucleotide polymorphisms (SNPs) within genes encoding for receptors for TNF (ie.<span class=""gene"" id=""28401452-4-198-206"">TNFRSF1A</span>) may change their function.",28401452,2018
Oral Mucositis,C1568868,CXCR2,3579,0.01,AlteredExpression,,BEFREE,"Genetic modification to induce <span class=""gene"" id=""29445104-0-31-36"">CXCR2</span> overexpression in mesenchymal stem cells enhances treatment benefits in radiation-induced <span class=""disease"" id=""29445104-0-127-141"">oral mucositis</span>.",29445104,2018
Oral Mucositis,C1568868,ABCC2,1244,0.01,GeneticVariation,,BEFREE,"The presence of ABCB1 3435-T, <span class=""gene"" id=""29885788-9-30-35"">ABCC2</span> 3972-C, <span class=""gene"" id=""29885788-9-44-49"">ABCC2</span> 1249-G, and ABCB1 2677-G alleles was significantly associated with nausea and <span class=""disease"" id=""29885788-9-128-142"">oral mucositis</span>.",29885788,2018
Oral Mucositis,C1568868,NBN,4683,0.31,Biomarker,,CTD_human,"Direct correlation of heterozygous and mutant alleles with acute reactions as well as haplotype correlation revealed <span class=""gene"" id=""24594932-6-117-120"">NBN</span> variants to be of predictive significance in analysing <span class=""disease"" id=""24594932-6-176-190"">oral mucositis</span> prior to radiotherapy.",24594932,2014
Oral Mucositis,C1568868,SIRT1,23411,0.01,Biomarker,,BEFREE,"Inhibition of <span class=""gene"" id=""31497199-0-14-19"">SIRT1</span> promotes taste bud stem cell survival and mitigates radiation-induced <span class=""disease"" id=""31497199-0-90-104"">oral mucositis</span> in mice.",31497199,2019
Oral Mucositis,C1568868,MTOR,2475,0.01,GeneticVariation,,BEFREE,"Of the oral mucosal toxicities observed with targeted therapies, <span class=""disease"" id=""30374901-6-65-79"">oral mucositis</span> is the most frequent with <span class=""gene"" id=""30374901-6-106-135"">mammalian target of rapamycin</span> (<span class=""gene"" id=""30374901-6-137-141"">mTOR</span>) inhibitors, followed by stomatitis associated to multikinase angiogenesis and HER inhibitors, geographic tongue, oral hyperkeratotic lesions, lichenoid reactions, and hyperpigmentation.",30374901,2018
Oral Mucositis,C1568868,XRCC5,7520,0.01,GeneticVariation,,BEFREE,"No association was found between Ku70 (c.-1310C&gt; G), <span class=""gene"" id=""24350917-10-53-57"">Ku80</span> (c.2099-2408G&gt; A, c.*841G&gt; A), DNA-PKcs (c.2888 + 713 C &gt; T) and the development of severe <span class=""disease"" id=""24350917-10-149-163"">oral mucositis</span>.",24350917,2014
Oral Mucositis,C1568868,CXCL8,3576,0.01,Biomarker,,BEFREE,"All non-interventional patients (controls) who developed grade 2 or higher <span class=""disease"" id=""28664388-8-75-77"">OM</span> induced an increase of <span class=""gene"" id=""28664388-8-101-106"">CXCL8</span> in saliva (n = 14) on D+7.",28664388,2017
Oral Mucositis,C1568868,RNR1,6052,0.01,GeneticVariation,,BEFREE,"Changes in the functioning of nucleotide synthesis pathway (<span class=""gene"" id=""29865035-2-60-64"">RNR1</span>, coded by RRM1 gene) can modulate the efficiency of cellular DNA repair mechanisms and influence the risk of occurrence and severity of <span class=""disease"" id=""29865035-2-201-203"">OM</span> in HNC patients after RTH.",29865035,2018
Oral Mucositis,C1568868,ABCB1,5243,0.02,GeneticVariation,,BEFREE,"<span class=""disease"" id=""23244145-5-0-14"">Oral mucositis</span> were detected in 78.7% (n=37) of the patients and significantly related to the <span class=""gene"" id=""23244145-5-94-99"">MDR-1</span> CT genotype (p=0.042), as confirmed by logistic regression analysis.",23244145,2012
Oral Mucositis,C1568868,SCT,6343,0.01,Biomarker,,BEFREE,"The efficacy of erythropoietin mouthwash in prevention of <span class=""disease"" id=""26310513-0-58-72"">oral mucositis</span> in patients undergoing autologous hematopoietic <span class=""gene"" id=""26310513-0-121-124"">SCT</span>: a double-blind, randomized, placebo-controlled trial.",26310513,2017
Oral Mucositis,C1568868,CSF2,1437,0.01,Biomarker,,BEFREE,"Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and <span class=""disease"" id=""11545238-0-73-87"">oral mucositis</span> in head and neck cancer patients receiving radiotherapy and <span class=""gene"" id=""11545238-0-148-196"">granulocyte-macrophage colony-stimulating factor</span> (<span class=""gene"" id=""11545238-0-198-204"">GM-CSF</span>) mouthwash.",11545238,2001
Oral Mucositis,C1568868,HMGB1,3146,0.01,Biomarker,,BEFREE,"In conclusion, our findings suggest that <span class=""gene"" id=""30647411-8-41-46"">HMGB1</span> plays a key role in the pathogenesis of <span class=""disease"" id=""30647411-8-87-89"">OM</span>; therefore, blockade of <span class=""gene"" id=""30647411-8-114-119"">HMGB1</span> by NecroX-7 may be a novel therapeutic strategy for <span class=""disease"" id=""30647411-8-172-174"">OM</span>.",30647411,2019
Oral Mucositis,C1568868,RAD51,5888,0.01,Biomarker,,BEFREE,"The meta-analysis showed an expression of polymorphisms in XRCC1 (32.66%), XRCC3 (31.00%), and <span class=""gene"" id=""28623401-7-95-100"">RAD51</span> (39.16%) genes, as well as an expression of protein biomarkers (39.57%), in patients with an increased risk of developing <span class=""disease"" id=""28623401-7-223-237"">oral mucositis</span>.",28623401,2017
Oral Mucositis,C1568868,NBN,4683,0.31,GeneticVariation,,BEFREE,"Direct correlation of heterozygous and mutant alleles with acute reactions as well as haplotype correlation revealed <span class=""gene"" id=""24594932-6-117-120"">NBN</span> variants to be of predictive significance in analysing <span class=""disease"" id=""24594932-6-176-190"">oral mucositis</span> prior to radiotherapy.",24594932,2014
Oral Mucositis,C1568868,EPO,2056,0.02,Biomarker,,BEFREE,"In the current study, we developed a thermally sensitive mucoadhesive gel based on trimethyl chitosan (TMC) containing <span class=""gene"" id=""30076521-3-119-122"">EPO</span> for the treatment of <span class=""disease"" id=""30076521-3-144-146"">OM</span>.",30076521,2018